Global (United States, European Union and China) Drug Repurposing Market Research Report 2019-2025

Published Date : 2019-08-12

Category : Pharma & Healthcare

No. of Pages : 116

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.
In 2019, the market size of Drug Repurposing is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug Repurposing.

This report studies the global market size of Drug Repurposing, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drug Repurposing sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
...

Market Segment by Product Type
Oncology
CNS Diseases
Neurodegenerative Diseases
Others

Market Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Drug Repurposing status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drug Repurposing manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Drug Repurposing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Drug Repurposing Market Size Growth Rate by Type (2019-2025)
1.3.2 Oncology
1.3.3 CNS Diseases
1.3.4 Neurodegenerative Diseases
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Drug Repurposing Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Drug Repurposing Market Size
2.1.1 Global Drug Repurposing Revenue 2014-2025
2.1.2 Global Drug Repurposing Sales 2014-2025
2.2 Drug Repurposing Growth Rate by Regions
2.2.1 Global Drug Repurposing Sales by Regions 2014-2019
2.2.2 Global Drug Repurposing Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Drug Repurposing Sales by Manufacturers
3.1.1 Drug Repurposing Sales by Manufacturers 2014-2019
3.1.2 Drug Repurposing Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Drug Repurposing Revenue by Manufacturers (2014-2019)
3.2.2 Drug Repurposing Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.3 Drug Repurposing Price by Manufacturers
3.4 Key Manufacturers Drug Repurposing Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Drug Repurposing Market
3.6 Key Manufacturers Drug Repurposing Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oncology Sales and Revenue (2014-2019)
4.1.2 CNS Diseases Sales and Revenue (2014-2019)
4.1.3 Neurodegenerative Diseases Sales and Revenue (2014-2019)
4.1.4 Others Sales and Revenue (2014-2019)
4.2 Global Drug Repurposing Sales Market Share by Type
4.3 Global Drug Repurposing Revenue Market Share by Type
4.4 Drug Repurposing Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Drug Repurposing Sales by Application

6 United States
6.1 United States Drug Repurposing Breakdown Data by Company
6.2 United States Drug Repurposing Breakdown Data by Type
6.3 United States Drug Repurposing Breakdown Data by Application

7 European Union
7.1 European Union Drug Repurposing Breakdown Data by Company
7.2 European Union Drug Repurposing Breakdown Data by Type
7.3 European Union Drug Repurposing Breakdown Data by Application

8 China
8.1 China Drug Repurposing Breakdown Data by Company
8.2 China Drug Repurposing Breakdown Data by Type
8.3 China Drug Repurposing Breakdown Data by Application

9 Rest of World
9.1 Rest of World Drug Repurposing Breakdown Data by Company
9.2 Rest of World Drug Repurposing Breakdown Data by Type
9.3 Rest of World Drug Repurposing Breakdown Data by Application
9.4 Rest of World Drug Repurposing Breakdown Data by Countries
9.4.1 Rest of World Drug Repurposing Sales by Countries
9.4.2 Rest of World Drug Repurposing Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Astellas Pharma
10.1.1 Astellas Pharma Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Drug Repurposing
10.1.4 Drug Repurposing Product Introduction
10.1.5 Astellas Pharma Recent Development
10.2 Biovista
10.2.1 Biovista Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Drug Repurposing
10.2.4 Drug Repurposing Product Introduction
10.2.5 Biovista Recent Development
10.3 Novartis
10.3.1 Novartis Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Drug Repurposing
10.3.4 Drug Repurposing Product Introduction
10.3.5 Novartis Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Drug Repurposing
10.4.4 Drug Repurposing Product Introduction
10.4.5 AbbVie Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Drug Repurposing
10.5.4 Drug Repurposing Product Introduction
10.5.5 Pfizer Recent Development
10.6 Allergan
10.6.1 Allergan Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Drug Repurposing
10.6.4 Drug Repurposing Product Introduction
10.6.5 Allergan Recent Development
10.7 NuMedii
10.7.1 NuMedii Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Drug Repurposing
10.7.4 Drug Repurposing Product Introduction
10.7.5 NuMedii Recent Development

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Drug Repurposing Sales Channels
11.2.2 Drug Repurposing Distributors
11.3 Drug Repurposing Customers

12 Market Forecast
12.1 Global Drug Repurposing Sales and Revenue Forecast 2019-2025
12.2 Global Drug Repurposing Sales Forecast by Type
12.3 Global Drug Repurposing Sales Forecast by Application
12.4 Drug Repurposing Forecast by Regions
12.4.1 Global Drug Repurposing Sales Forecast by Regions 2019-2025
12.4.2 Global Drug Repurposing Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer


List of Tables and Figures

Figure Drug Repurposing Product Picture
Table Drug Repurposing Key Market Segments
Table Major Manufacturers Drug Repurposing Covered in This Report
Table Global Drug Repurposing Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
Figure Global Drug Repurposing Sales Market Shar by Type 2014-2025
Figure Oncology Figures
Table Major Manufacturers of Oncology
Figure CNS Diseases Figures
Table Major Manufacturers of CNS Diseases
Figure Neurodegenerative Diseases Figures
Table Major Manufacturers of Neurodegenerative Diseases
Figure Others Figures
Table Major Manufacturers of Others
Table Global Drug Repurposing Market Share by Application 2019-2025 (K MT)
Figure Hospitals Use Case
Figure Ambulatory Surgical Centers Use Case
Figure Others Use Case
Figure Drug Repurposing Report Years Considered
Figure Global Drug Repurposing Market Size 2014-2025 (Million US$)
Figure Global Drug Repurposing Sales 2014-2019 (K MT)
Table Global Drug Repurposing Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Drug Repurposing Sales by Regions 2014-2019 (K MT)
Table Global Drug Repurposing Sales Market Share by Regions 2014-2019
Figure Global Drug Repurposing Sales Market Share by Regions 2014-2019
Figure Global Drug Repurposing Sales Market Share by Regions in 2019
Table Global Drug Repurposing Revenue by Regions 2014-2019 (Million US$)
Table Global Drug Repurposing Revenue Market Share by Regions 2014-2019
Figure Global Drug Repurposing Revenue Market Share by Regions 2014-2019
Figure Global Drug Repurposing Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Drug Repurposing Sales by Manufacturers (2014-2019) (K MT)
Table Global Drug Repurposing Sales Share by Manufacturers (2014-2019)
Figure Global Drug Repurposing Sales Share by Manufacturers in 2019
Table Drug Repurposing Revenue by Manufacturers (2014-2019) (Million USD)
Table Drug Repurposing Revenue Share by Manufacturers (2014-2019)
Figure Drug Repurposing Value Share by Manufacturers in 2019
Table Global Drug Repurposing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Drug Repurposing Price (2014-2019) (USD/MT)
Table Key Manufacturers Drug Repurposing Plants/Factories Distribution
Table Key Manufacturers Drug Repurposing Area Served
Table Date of Key Manufacturers Enter into Drug Repurposing Market
Table Key Manufacturers Drug Repurposing Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global CNS Diseases Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Neurodegenerative Diseases Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Others Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Drug Repurposing Sales by Type (2014-2019) (K MT)
Table Global Drug Repurposing Sales Share by Type (2014-2019)
Figure Global Drug Repurposing Sales Market Share by Type (2014-2019)
Figure Global Drug Repurposing Sales Market Share by Type in 2018
Table Global Drug Repurposing Revenue by Type (2014-2019) (Million US$)
Table Global Drug Repurposing Revenue Share by Type (2014-2019)
Figure Global Drug Repurposing Revenue Market Share by Type (2014-2019)
Figure Global Drug Repurposing Revenue Market Share by Type in 2018
Table Drug Repurposing Price by Type 2014-2019 (USD/MT)
Table Global Drug Repurposing Sales by Application (2014-2019) (K MT)
Table Global Drug Repurposing Sales Share by Application (2014-2019)
Figure Global Sales Drug Repurposing Market Share by Application (2014-2019)
Figure Global Sales Drug Repurposing Market Share by Application (2014-2019)
Figure United States Drug Repurposing Sales Growth Rate 2014-2019 (K MT)
Figure United States Drug Repurposing Revenue Growth Rate 2014-2019 (Million US$)
Table United States Drug Repurposing Sales by Company (2014-2019) (K MT)
Table United States Drug Repurposing Sales Market Share by Company (2014-2019)
Figure United States Drug Repurposing Sales Market Share by Company in 2019
Table United States Drug Repurposing Sales by Type (2014-2019) (K MT)
Table United States Drug Repurposing Sales Market Share by Type (2014-2019)
Figure United States Drug Repurposing Market Share by Type in 2019
Table United States Drug Repurposing Sales by Application (2014-2019) (K MT)
Table United States Drug Repurposing Sales Market Share by Application (2014-2019)
Figure United States Drug Repurposing Market Share by Application in 2019
Figure European Union Drug Repurposing Sales Growth Rate 2014-2019 (K MT)
Figure European Union Drug Repurposing Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Drug Repurposing Sales by Company (2014-2019) (K MT)
Table European Union Drug Repurposing Sales Market Share by Company (2014-2019)
Figure European Union Drug Repurposing Sales Market Share by Company in 2019
Table European Union Drug Repurposing Sales by Type (2014-2019) (K MT)
Table European Union Drug Repurposing Sales Market Share by Type (2014-2019)
Figure 2018 European Union Drug Repurposing Market Share by Type
Table European Union Drug Repurposing Sales by Application (2014-2019) (K MT)
Table European Union Drug Repurposing Sales Market Share by Application (2014-2019)
Figure 2018 European Union Drug Repurposing Market Share by Application
Figure China Drug Repurposing Sales Growth Rate 2014-2019 (K MT)
Figure China Drug Repurposing Revenue Growth Rate 2014-2019 (Million US$)
Table China Drug Repurposing Sales by Company (2014-2019) (K MT)
Table China Drug Repurposing Sales Market Share by Company (2014-2019)
Figure China Drug Repurposing Sales Market Share by Company in 2019
Table China Drug Repurposing Sales by Type (2014-2019) (K MT)
Table China Drug Repurposing Sales Market Share by Type (2014-2019)
Figure China Drug Repurposing Market Share by Type in 2019
Table China Drug Repurposing Sales by Application (2014-2019) (K MT)
Table China Drug Repurposing Sales Market Share by Application (2014-2019)
Figure China Drug Repurposing Market Share by Application in 2019
Figure Rest of World Drug Repurposing Sales Growth Rate 2014-2019 (K MT)
Figure Rest of World Drug Repurposing Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Drug Repurposing Sales by Company (2014-2019) (K MT)
Table Rest of World Drug Repurposing Sales Market Share by Company (2014-2019)
Figure Rest of World Drug Repurposing Sales Market Share by Company in 2019
Table Rest of World Drug Repurposing Sales by Type (2014-2019) (K MT)
Table Rest of World Drug Repurposing Sales Market Share by Type (2014-2019)
Figure Rest of World Drug Repurposing Market Share by Type in 2019
Table Rest of World Drug Repurposing Sales by Application (2014-2019) (K MT)
Table Rest of World Drug Repurposing Sales Market Share by Application (2014-2019)
Figure Rest of World Drug Repurposing Market Share by Application in 2019
Table Rest of World Drug Repurposing Sales by Countries (2014-2019) (K MT)
Table Rest of World Drug Repurposing Sales Market Share by Countries (2014-2019)
Figure Rest of World Drug Repurposing Sales Market Share by Countries in 2019
Table Rest of World Drug Repurposing Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Drug Repurposing Revenue Market Share by Countries (2014-2019)
Figure Rest of World Drug Repurposing Revenue Market Share by Countries in 2019
Figure Japan Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Japan Drug Repurposing Revenue Growth Rate (2014-2019) (K MT)
Figure Korea Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Korea Drug Repurposing Revenue Growth Rate (2014-2019) (K MT)
Figure India Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure India Drug Repurposing Revenue Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Drug Repurposing Revenue Growth Rate (2014-2019) (K MT)
Table Astellas Pharma Company Details
Table Astellas Pharma Description and Business Overview
Table Astellas Pharma Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Astellas Pharma Drug Repurposing Sales Growth Rate (2014-2019)
Table Astellas Pharma Drug Repurposing Sales Market Share in Global Market
Table Astellas Pharma Recent Development
Table Biovista Company Details
Table Biovista Description and Business Overview
Table Biovista Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Biovista Drug Repurposing Sales Growth Rate (2014-2019)
Table Biovista Drug Repurposing Sales Market Share in Global Market
Table Biovista Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Drug Repurposing Sales Growth Rate (2014-2019)
Table Novartis Drug Repurposing Sales Market Share in Global Market
Table Novartis Recent Development
Table AbbVie Company Details
Table AbbVie Description and Business Overview
Table AbbVie Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table AbbVie Drug Repurposing Sales Growth Rate (2014-2019)
Table AbbVie Drug Repurposing Sales Market Share in Global Market
Table AbbVie Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Drug Repurposing Sales Growth Rate (2014-2019)
Table Pfizer Drug Repurposing Sales Market Share in Global Market
Table Pfizer Recent Development
Table Allergan Company Details
Table Allergan Description and Business Overview
Table Allergan Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Allergan Drug Repurposing Sales Growth Rate (2014-2019)
Table Allergan Drug Repurposing Sales Market Share in Global Market
Table Allergan Recent Development
Table NuMedii Company Details
Table NuMedii Description and Business Overview
Table NuMedii Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table NuMedii Drug Repurposing Sales Growth Rate (2014-2019)
Table NuMedii Drug Repurposing Sales Market Share in Global Market
Table NuMedii Recent Development
Figure Drug Repurposing Value Chain
Table Drug Repurposing Distributors List
Table Drug Repurposing Customers List
Table Global Drug Repurposing Sales Forecast 2019-2025 (K MT) & (Million US$)
Figure Global Drug Repurposing Sales Forecast 2019-2025 (K MT)
Figure Global Drug Repurposing Revenue Forecast 2019-2025 (Million US$)
Table Global Drug Repurposing Sales Forecast by Type 2019-2025 (K MT)
Figure Global Drug Repurposing Sales Forecast by Type 2019-2025 (K MT)
Figure Global Drug Repurposing Sales Market Share Forecast by Type 2019-2025
Table Global Drug Repurposing Sales Forecast by Application 2019-2025 (K MT)
Figure Global Drug Repurposing Sales Forecast by Application 2019-2025 (K MT)
Figure Global Drug Repurposing Sales Market Share Forecast by Application 2019-2025
Table Global Drug Repurposing Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Drug Repurposing Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Drug Repurposing Sales Market Share Forecast by Regions 2019-2025
Table Global Drug Repurposing Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Drug Repurposing Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Drug Repurposing Revenue Market Share Forecast by Regions 2019-2025
Figure United States Drug Repurposing Sales Forecast 2019-2025 (K MT)
Figure United States Drug Repurposing Revenue Forecast 2019-2025 (Million US$)
Figure European Union Drug Repurposing Sales Forecast 2019-2025 (K MT)
Figure European Union Drug Repurposing Revenue Forecast 2019-2025 (Million US$)
Figure China Drug Repurposing Sales Forecast 2019-2025 (K MT)
Figure China Drug Repurposing Revenue Forecast 2019-2025 (Million US$)
Figure Japan Drug Repurposing Sales Forecast 2019-2025 (K MT)
Figure Japan Drug Repurposing Revenue Forecast 2019-2025 (Million US$)
Figure Korea Drug Repurposing Sales Forecast 2019-2025 (K MT)
Figure Korea Drug Repurposing Revenue Forecast 2019-2025 (Million US$)
Figure India Drug Repurposing Sales Forecast 2019-2025 (K MT)
Figure India Drug Repurposing Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Drug Repurposing Sales Forecast 2019-2025 (K MT)
Figure Southeast Asia Drug Repurposing Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Drug Repurposing  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com